Comment: Barbiturates may possibly enhance adverse consequences, which include respiratory despair, produced by poisonous doses of TCAs. With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.On initiation or discontinuation of secukinumab in patients that are receiving concomitant CYP450 substrate